Pharmathene, INC
SEC CIK 1326190 · PIP · last insider filing 2026-05-01
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Sayare Mitchel | Director | filed 2010 - 2026 |
| Gill John | Director · President and CEO | filed 2007 - 2026 |
| Jorkasky Diane | Director | filed 2020 - 2026 |
| Sohn Catherine A. | Director | filed 2023 - 2026 |
| Hodges Philip | Director | filed 2017 - 2026 |
| Schafer Klaus | Director | filed 2017 - 2026 |
| Pisano Wayne | Director | filed 2018 - 2026 |
| Lawver Teri L | Director | filed 2025 - 2026 |
| Durso Jerome Benedict | Director · President and CEO | filed 2025 - 2026 |
| Garg Vipin K | Director · President and CEO | filed 2018 - 2026 |
| Harris Matthew Scott | Director · Chief Medical Officer | filed 2019 - 2025 |
| Drutz David | Director | filed 2017 - 2024 |
| Enright William | Director · See Remarks | filed 2017 - 2018 |
| Schaffer Derace L | Director · Vice Chairman and CEO | filed 2007 - 2018 |
| Redmont Vaxn Capital Holdings, LLC | Director | filed 2017 - 2017 |
| Czerepak Elizabeth | Director · See Remarks | filed 2007 - 2017 |
| Runge Jeffrey W. | Director | filed 2009 - 2017 |
| St Peter Steven | Director | filed 2007 - 2017 |
| Richman Eric I | Director · Sr. VP, Business Development | filed 2007 - 2016 |
| Markison Brian A | Director | filed 2011 - 2015 |
| Mccleary Joel | Director | filed 2007 - 2015 |
| Pappajohn John | Director · Chairman and Secretary | filed 2007 - 2011 |
| Cavanaugh James H | Director | filed 2007 - 2010 |
| Wright David P | Director · President and CEO | filed 2007 - 2009 |
| Kinley Matthew P | Director · President & Treasurer | filed 2007 - 2007 |
| Berger Edward B | Director | filed 2007 - 2007 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Weaver Gregory L | Chief Financial Officer | filed 2024 - 2026 |
| Roberts M Scot | Chief Scientific Officer | filed 2017 - 2026 |
| Jordt Raymond M | Chief Business Officer | filed 2023 - 2026 |
| Arbet-Engels Christophe | Chief Medical Officer | filed 2025 - 2025 |
| Richardson Linda M | Chief Commercial Officer | filed 2025 - 2025 |
| Shutterly Andrew | See Remarks | filed 2024 - 2024 |
| Eisenstadt Richard I | Chief Financial Officer | filed 2022 - 2024 |
| Brown William Michael | Chief Financial Officer | filed 2018 - 2021 |
| Tasker Sybil | See Remarks | filed 2017 - 2019 |
| Macneill Philip | VP, CFO, Treasurer, Secretary | filed 2011 - 2016 |
| Jones Jeffrey Michael | COO | filed 2015 - 2015 |
| Chang Linda L | SVP, CFO & Secretary | filed 2011 - 2015 |
| Cook Francesca M | VP, Policy & Gov't. Affairs | filed 2007 - 2014 |
| Morges Wayne | VP, Regulatory Affairs & Qual | filed 2007 - 2014 |
| Karp Jordan P | Sr. V-P and General Counsel | filed 2008 - 2012 |
| Fuerst Thomas Richard | SVP, Chief Scientific Officer | filed 2010 - 2011 |
| Riddle Valerie D | VP, Medical Director | filed 2007 - 2011 |
| Reinhart Charles A. III | Senior Vice President and CFO | filed 2009 - 2010 |
| Fusco Joan | Sr Vice President, Operations | filed 2008 - 2010 |
| Camut Christopher C | VP, Gov't Contracts | filed 2007 - 2010 |
| Price Kevin | President-Pharmathene UK, Ltd. | filed 2008 - 2009 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.